Both in Pharmaceuticals
Journey Medical vs Pyxis Oncology
Over the past year DERM returned −45.5% and PYXS returned −57.0%; their daily moves had a correlation of 0.08.
DERM −45.5% PYXS −57.0%Growth of $1, one year, split-adjusted
| Metric | DERM | PYXS |
|---|---|---|
| Price | $4.64 | $1.64 |
| Market cap | $131.0M | $136.8M |
| Today | −3.13% | −2.96% |
| 1 month | −30.6% | −26.8% |
| 6 months | −10.4% | −10.4% |
| Year to date | −39.8% | +42.6% |
| 1 year | −42.9% | −53.9% |
| Revenue growth (YoY) | +18.9% | −100.0% |
| Gross margin | 65.6% | — |
| Net margin | −1.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | 12.4× |
| Net cash | -$245.0K | $33.0M |
| Dividend yield | — | — |
| Volatility (60d) | 64.3% | 112.4% |
| Short % of float | 24.8% | 7.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).